Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-14 Sale | 2026-05-14 7:37 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 20,311 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:34 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 76,650 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:34 pm | Apellis Pharmaceuticals Inc. | APLS | Dolsten Mikael Director | 14,312 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:32 pm | Apellis Pharmaceuticals Inc. | APLS | MELTZER LESLIE Chief Research and Development | 174,854 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:31 pm | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 24,188 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:30 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 270,413 | $0 | $0 | 0 (Indirect Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:29 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 20,311 | $0 | $0 | 0 (Indirect Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:27 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 135,445 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:26 pm | Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director | 24,188 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:25 pm | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 221,303 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:24 pm | Apellis Pharmaceuticals Inc. | APLS | Walbert Keli Director | 16,293 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:23 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 186,543 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:22 pm | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 24,188 | $0 | $0 | 0 (Indirect Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:20 pm | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 173,023 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:19 pm | Apellis Pharmaceuticals Inc. | APLS | WHEELER CRAIG A Director | 23,071 | $0 | $0 | 0 (Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:19 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 267,033 | $0 | $0 | 0 (Indirect Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:17 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 875,644 | $0 | $0 | 0 (Indirect Direct) | View |
| 2026-05-14 Sale | 2026-05-14 7:16 pm | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 118,953 | $0 | $0 | 0 (Direct) | View |
| 2026-02-11 Sale | 2026-02-13 09:23 am | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 368 | $22.15 | $8,153 | 114,591 (Direct) | View |
| 2026-01-22 Sale | 2026-01-23 4:13 pm | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 2,797 | $21.77 | $60,878 | 86,527 (Direct) | View |
| 2026-01-22 Sale | 2026-01-23 4:12 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 2,064 | $21.77 | $44,924 | 49,805 (Direct) | View |
| 2026-01-22 Sale | 2026-01-23 4:11 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 3,371 | $21.77 | $73,371 | 78,353 (Direct) | View |
| 2026-01-22 Sale | 2026-01-23 4:10 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 5,928 | $21.77 | $129,025 | 1,151,382 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-14 Equity Swap | 2026-05-14 7:37 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 161,567 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:34 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 65,955 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:34 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 38,244 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:34 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dolsten Mikael Director | 14,312 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:32 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | MELTZER LESLIE Chief Research and Development | 107,024 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:32 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | MELTZER LESLIE Chief Research and Development | 67,830 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:31 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director | 30,666 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:30 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 212,437 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:30 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 159,080 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:29 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 796,939 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:27 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 1,177,222 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:27 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 90,040 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:26 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director | 25,666 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:25 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 116,338 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:25 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 133,364 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:24 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Walbert Keli Director | 17,051 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:23 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 114,591 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:23 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 115,165 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:22 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 31,416 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 127,804 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 45,219 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | WHEELER CRAIG A Director | 24,444 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 204,653 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 153,737 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:17 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 1,805,259 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:17 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 524,786 | $0 | 0 (Direct) | View |
| 2026-05-14 Equity Swap | 2026-05-14 7:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 86,525 | $0 | 0 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-14 7:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 67,646 | $0 | 0 (Direct) | View |
| 2026-04-29 Gift | 2026-05-01 4:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 900 | $0 | 86,525 (Direct) | View |
| 2026-04-17 Gift | 2026-04-20 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 11,096 | $0 | 212,437 (Direct) | View |
| 2026-04-06 Other | 2026-04-08 4:26 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 5,750 | $0 | 37,166 (Indirect) | View |
Ownership | 2026-04-06 6:11 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | BIOGEN INC. See footnotes | 0 | $0 | 0 (Indirect) | View |
| 2026-03-11 Gift | 2026-03-13 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 64,869 | $0 | 1,805,259 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-03 4:06 pm | N/A 2036-02-27 | Apellis Pharmaceuticals Inc. | APLS | Dolsten Mikael Director | 24,135 | $20.96 | 38,447 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-03 4:06 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dolsten Mikael Director | 14,312 | $0 | 38,447 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 4:14 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 8,840 | $3.76 | 1,805,259 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 4:14 pm | N/A 2026-02-06 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 8,840 | $0 | 1,805,259 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:13 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 30,146 | $0 | 127,804 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 16,150 | $0 | 65,955 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:11 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 36,606 | $0 | 114,959 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:10 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 25,840 | $0 | 1,177,222 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:09 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | MELTZER LESLIE Chief Research and Development | 45,220 | $0 | 107,024 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 45,220 | $0 | 116,338 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:07 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 58,140 | $0 | 212,437 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:06 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 55,986 | $0 | 204,653 (Direct) | View |
| 2026-01-28 Option Award | 2026-01-30 4:05 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 195,952 | $0 | 1,796,419 (Direct) | View |